However, no significant difference in mortality found between remdesivir and placebo groups

Most older adults taking multiple medications have never had a comprehensive medication review

No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir

No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19